Asensus Surgical reports Q2 EPS (7c), consensus (6c)

Reports Q2 revenue $2.21M, consensus $1.23M.”We’re at a critical juncture for our company. After thoroughly exploring all reasonably available options, we believe the Merger proposal offers the best opportunity to maximize value for our stockholders in our current circumstances,” said Anthony Fernando, Asensus Surgical President and CEO. “While we understand the offer price may not meet everyone’s expectations, it does provide a definite return in a challenging financial environment. If the Merger is not approved, we expect to seek bankruptcy protection. We encourage all stockholders to carefully review the information we’ve provided and to participate in this crucial vote. Every vote matters as we determine the best path forward for Asensus Surgical and all of our stakeholders.”